• Home
  • NEW DAY MEDICINE
  • 1 (29) 2020 г.
  • 118 -1 (29/3) 2020 — Khodjieva D.T., Khaydarova D.K., — CLINICAL — NEUROIMAGING CHARACTERISTIC IN PATIENTS WITH POST-INSULAR COGNITIVE IMPAIRMENT AND QUESTIONS OF OPTIMIZATION OF THERAPY

118 -1 (29/3) 2020 — Khodjieva D.T., Khaydarova D.K., — CLINICAL — NEUROIMAGING CHARACTERISTIC IN PATIENTS WITH POST-INSULAR COGNITIVE IMPAIRMENT AND QUESTIONS OF OPTIMIZATION OF THERAPY

CLINICAL – NEUROIMAGING CHARACTERISTIC IN PATIENTS WITH POST-INSULAR COGNITIVE IMPAIRMENT AND QUESTIONS OF OPTIMIZATION OF THERAPY

Khodjieva D.T., Bukhara State Medical Institute.

Khaydarova D.K., Bukhara State Medical Institute.

Djunaidova A.H., Bukhara State Medical Institute.

Resume,

The purpose this article suggests the treatment of an acute period of ischemic stroke with cytoflavin, which improves cognitive functions – speech, attention, orientation, praxis and gnosis, which is confirmed by the results of neuroimaging studies. With neuroimaging, in most patients, along with focal post-stroke changes, brain atrophy, changes in white matter, and small-focal lesions of gray matter were detected.

Key words: ischemic stroke; cytoflavin; magnetic resonance imaging

First page

436

Last page

439

For citation: Khodjieva D.T., Khaydarova D.K., Djunaidova A.H., Clinical – neuroimaging characteristic in patients with post-insular cognitive impairment and questions of optimization of therapy//New Day in Medicine 1(29)2020 436-439 https://cutt.ly/8bqsii0

List of References

  1. Guti?rrez P?rez C, Savborg M, Pahlman U, P?hlman U, Cederfeldt M, Knopp E, Nordlund A, Astrand R, Wallin A, Fr?jd K, Wijk H, Tarkowski E. High frequency of cognitive dysfunction before stroke among older people. Int J Geriatr Psychiatry. 2011; 26: 622-629. doi: 10.1002/gps.2573.
  2. Looi JCL, Sachdev P. Differentiation of vascular dementia from AD on neuropsychological tests. Neurology.1999; 53: 670-678. doi: 10.1212/wnl.53.4.670.
  3. Sachdev PS, Chen X, Brodaty H, Thompson C, Altendorf A, Wen W. The determinants and longitudinal course of post-strokemild cognitive impairment. J Int Neuropsychol Soc. 2009; 15: 915­923. doi: 10.1017/S1355617709990579.
  4. Gorelick PB, Scuteri A, Black SE, Decarli C, Greenberg SM, Iadecola C, Launer LJ, Laurent S, Lopez OL, Nyenhuis D, Petersen RC, Schneider JA, Tzourio C, Arnett DK, Bennett DA, Chui HC, Higashida RT, Lindquist R, Nilsson PM, Roman GC, Sellke FW, Seshadri S. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American heart association /American stroke association. Stroke.2011; 42(9):2672-2713. doi: 10.1161/STR.0b013e3182299496.
  5. Petersen R.C. Mild cognitive impairment as a diagnostic entity. J Intern Med. 2004; 256(3): 183-194. doi: 10.1111/j.1365- 2796.2004.01388.x.
  6. Cho S.J., Yu K.H., Oh M.S., Jung S., Lee J.H., Koh I.S., Bae H.J., Kang Y., Lee B.C. Post-stroke memory impairment among patients with vascular mild cognitive impairment. BMC Neurol. 2014; 20(14): 244. doi: 10.1186/s12883-014-0244-6.
  7. Snaphaan L, de Leeuw F-E. Poststroke memory function in nondemented patients: a systematic review on frequency and neuroimaging correlates. Stroke. 2007; 38:198-203. doi: 10.1161/ 01.str.0000251842.34322.8f.
  8. Liu W., Wong A., Au L., Yang J., Wang Z., Leung E.Y., Chen S., Ho C.L., Mok V.C. Influence of amyloid-? on cognitive decline after stroke/transient ischemic attack: Three-Year Longitudinal Study. Stroke. 2015; 46(11): 3074-3080. doi: 10.1161/ STROKEAHA.115.010449.
  9. Jang Y.K., Kwon H., Kim Y.J., Jung N.Y., Lee J.S., Lee J., Chin J., Im K., Jeon S., Lee J.M., Seong J.K., Kim J.H., Kim S., Choe Y.S., Lee K.H., Kim S.T., Kim J.S., Lee J.H., Na D.L., Seo S.W., Kim H.J. Early-vs late-onset subcortical vascular cognitive impairment. Neurology. 2016; doi: 10.1212/WNL.0000000000002357.
  10. Jack CR Jr, Therneau T.M., Wiste H.J., Weigand S.D., Knopman D.S., Lowe V.J., Mielke M.M., Vemuri P., Roberts R.O., Machulda M.M., Senjem M.L., Gunter J.L., Rocca W.A., Petersen R.C. Transition rates between amyloid and neurodegeneration biomarker states and to dementia: a population-based, longitudinal cohort study. Lancet Neurol. 2016; 15(1):56-64. doi: 10.1016/S1474-4422(15)00323-3.
  11. Ходжиева Д.Т., Маджидова Ё.Н., Хайдарова Д.К. Вызватаые потещиаёы мозга у больных с умеренными когнитивными сосудистами расстройствами дисциркуляторной эщефало- патией при лечении питофлавином // Журнал неврологии и психиатрии им. С.С. Корсакова. – С.Петербург, 2013. – Том 113, №8. – С.42-45.
  12. Ходжиева Д.Т., Хайдаров Н.К. Хайдарова Д.К. Коррекция асте^о^евротического сивдрома энергокорректором питофлавином // неврология. – 2013. – №3. С.16-19.
  13. Ходжиева Д.Т. Влияние нейроиммунологических показателей больных с и0емическим инсультом на развитие иостин- сультной демещии //Тиббиётда яши кун. – 2019; 2(28): 40­47. https://www.bsmi.uz/images/material_2 019/yanvar/jurnal/ 2018-2.pdf
  14. Ходжиева Д.Т., Хайдарова Д.К. Хайдаров Н.К. Совершен­ствование диагностической тактики иостинсультных когни­тивных расстройств //Биомедипина. – 2019; 5: 80-86.
  15. Ходжиева Д.Т. Клинико-неврологическая и параклиническая характеристика больных с ишемическим инсультом в зави­симости от наличия когнитивного дефипита // ^евроёо- гия- 2019; 4: 29-33.
  16. Khodzhieva D.T. Low-dose neuroprotection in case of cognitive disorders in patients with ischemic stroke // International Journal of Pharmaceutical Research. July – 2019. 11. Issue 3.С.1167-1170.
  17. Khodzhieva D.T. Clinical – Neurophysiological Characterization of Postinsular Cognitive Disorders and Issues of Therapy Optimization // International Journal of Bioscience and Biotechnology (IJBSBT) ISSN. – 2233-7849.-Vol.11- 2019. – С.27-35.
  18. Khodzhieva D.T. Ways To Optimize Therapy For Post-Stroke Cognitive Disorders // International Journal of Bioscience and Biotechnology (IJBSBT) ISSN: 2233-7849 Vol.-2019 – С.36-45.

file

download